A few years ago I wrote an editorial expressing my concerns about the diagnoses of Wilson’s syndrome and adrenal fatigue, both of which naturopaths consider common disorders (TDF: Trendy diagnosis fatigue, BCMJ 2007;49:471). At that time I was not familiar with the complete treatment protocol for Wilson’s syndrome.
Since that time there have been reports of patients who have developed overt hyperthyroidism and cardiac dysrhythmias, particularly atrial fibrillation while on this treatment, and I thought it important that the potential risks of this treatment be brought forward.
On reviewing the details of this treatment, I found that the use of “supraphysiologic cyclic dosing” of slow release T3 (liothyronine) is used to “reset low body temperature and recalibrate metabolic rate” (really?). Body temperature alone is used to determine dose and treatment cycle length. In brief, the protocol involves starting T3 at 7.5 µg every 12 hours and increasing by 7.5 µg daily until temperature reaches 37 °C.
Sometimes doses up to 90–105 µg twice daily are needed to achieve this. If the target temperature is not reached once these high doses are used, the dose is tapered by 7.5 µg every 2 days down to nothing, then the cycle restarted. The cycles are repeated until target temperature is reached. In many patients it may take months and in some it is never achieved. If it is reached then that dose is maintained for a few weeks, then tapered off, to begin again if symptoms recur.
A large proportion of patients are very likely to be hyperthyroid for significant periods of time during this treatment. In fact, one article describing the treatment stated that a significant number of patients suffer from symptoms of increased heart rate, irritability, and shakiness. Is this surprising? Sounds suspiciously like hyperthyroidism to me.
No mention was made of thyroid levels being measured when those symptoms occurred. If one were to treat hypothyroidism with T3 alone (which is not common practice, at least among endocrinologists), most individuals would not require more than 75 mcg daily. Fortunately, atrial fibrillation occurring in this setting resolves once the thyroid levels normalize (off T3).
Atrial fibrillation is a common dysrhythmia, and in the investigation of possible reversible causes of it, thyroid levels are routinely measured to rule out hyperthyroidism. Iatrogenic hyperthyroidism, from what is in my view inappropriate and injudicious use of thyroid hormone, is harmful and potentially dangerous.
Above is the information needed to cite this article in your paper or presentation. The International Committee
of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally
accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
About the ICMJE and citation styles
The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.
An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.
BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:
- Only the first three authors are listed, followed by "et al."
- There is no period after the journal name.
- Page numbers are not abbreviated.
For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org